HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein.

Abstract
AML1 is a transcription factor that is essential for normal hematopoietic development. It is the most frequent target for translocations in acute leukemia. Recently, fluorescence in situ hybridization was used to identify a novel syndrome of radiation-associated secondary acute myelogenous leukemia that had AML1 translocations. Using polymerase chain reaction, the AML1 fusion transcript was isolated from the patient who had a t(19;21) radiation-associated leukemia. The AML1 gene is fused out of frame to chromosome 19 sequences, resulting in a truncated AML protein bearing the DNA binding domain but not the transcriptional activation domain. This fusion AML1 protein functions as an inhibitor of the normal AML1 protein. (Blood. 2001;97:2168-2170)
AuthorsR Hromas, T Busse, A Carroll, D Mack, R Shopnick, D E Zhang, H Nakshatri, K Richkind
JournalBlood (Blood) Vol. 97 Issue 7 Pg. 2168-70 (Apr 01 2001) ISSN: 0006-4971 [Print] United States
PMID11264187 (Publication Type: Journal Article)
Chemical References
  • AML1-AMP19 fusion protein, human
  • Core Binding Factor Alpha 2 Subunit
  • DNA, Complementary
  • DNA-Binding Proteins
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins
  • RUNX1 protein, human
  • Recombinant Fusion Proteins
  • Transcription Factors
Topics
  • Acute Disease
  • Amino Acid Sequence
  • Base Sequence
  • Binding Sites (genetics)
  • Chromosomes, Human, Pair 19 (genetics, ultrastructure)
  • Chromosomes, Human, Pair 21 (genetics, ultrastructure)
  • Core Binding Factor Alpha 2 Subunit
  • DNA, Complementary (genetics)
  • DNA-Binding Proteins (antagonists & inhibitors, chemistry, genetics)
  • Humans
  • In Situ Hybridization
  • Leukemia, Myeloid (etiology, genetics)
  • Leukemia, Radiation-Induced (genetics)
  • Molecular Sequence Data
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins (chemistry, genetics, pharmacology)
  • Sequence Deletion
  • Transcription Factors (antagonists & inhibitors, chemistry, genetics)
  • Transcriptional Activation (genetics)
  • Translocation, Genetic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: